Improving HIV prevention strategies in Botswana
Evaluation of PrEP implementation strategies for the general population in Botswana
This study is all about finding better ways to help people in Botswana learn about and access PrEP, a medication that can prevent HIV, especially focusing on younger folks who are often on the move and use technology a lot.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Botswana NIH-funded |
| Lab location | 1 site (Gaborone, Botswana) |
| Project ID | NIH-11161430 on NIH RePORTER |
What this research studies
This research focuses on developing and testing new strategies to improve the implementation of pre-exposure prophylaxis (PrEP) for HIV prevention among the general population in Botswana. It aims to address barriers to PrEP uptake, such as lack of knowledge and social support, particularly targeting younger, mobile, and digitally connected individuals. The study will collaborate with policymakers and healthcare providers to create effective outreach and education programs. By leveraging existing healthcare infrastructure, the research seeks to enhance access to PrEP and ultimately reduce new HIV infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include young adults and adolescents in Botswana who are at risk of HIV infection and are seeking preventive options.
Not a fit: Patients who are already HIV positive or those who do not have access to healthcare facilities in Botswana may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rate of new HIV infections in Botswana by improving access to preventive treatments.
How similar studies have performed: Previous research has shown success in implementing PrEP strategies in targeted populations, indicating potential for positive outcomes in broader populations as well.
Where this research is happening
Gaborone, Botswana
- University of Botswana — Gaborone, Botswana (Active)
Researchers
- Principal investigator: Mosepele, Mosepele — University of Botswana
- Study coordinator: Mosepele, Mosepele
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.